prof. dr. J. (Jan) Pruim

Nuclear Medicine Physician/Professor of Medical Imaging

prof. dr. J. (Jan) Pruim
Telephone:
+31 50 361 3503 (office)
+31 50 361 2205 (secretary)
E-mail:
j.pruim umcg.nl

Research

  1. 2003
  2. 2002
  3. Fontan, A., Rojo, A., Pernaute, RS., Hernandez, N. V., Lopez, N. V., Castilla, C., ... de Yebenes, JG. (2002). Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates. Parkinsonism & Related Disorders, 8(5), 311-323. [PII S1353-8020(02)00005-6].
  4. 2001
  5. Siebelink, HMJ., Blanksma, PK., Crijns, HJGM., Bax, JJ., van Boven, AJ., Kingma, T., ... van der Wall, EE. (2001). Patient management guided by viability imaging - Reply. Journal of the American College of Cardiology, 38(4), 1272-1273.
  6. Portman, AT., Giladi, N., Leenders, KL., Maguire, P., Veenma-van der Duin, L., Swart, J., ... Korczyn, AD. (2001). The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations. Neurology, 56(12), 1759-1762.
  7. 2000
  8. Passchier, J., van Waarde, A., Pieterman, RM., Elsinga, PH., Pruim, J., Hendrikse, HN., ... Vaalburg, W. (2000). In vivo delineation of 5-HT1A receptors in human brain with [F-18]MPPF. Journal of Nuclear Medicine, 41(11), 1830-1835.
  9. Pieterman, RM., van Putten, JWG., Meuzelaar, JJ., Mooyaart, EL., Vaalburg, W., Koeter, GH., ... Groen, HJM. (2000). Preoperative staging of non-small-cell lung cancer with positron-emission tomography. New England Journal of Medicine, 343(4), 254-261.
  10. 1999
  11. Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, AA., ... European Org Res Treatment Canc (1999). Measurement of clinical and subclinical tumour response using [F-18]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. European Journal of Cancer, 35(13), 1773-1782.
  12. 1998
  13. Kole, AC., Nieweg, OE., Pruim, J., Hoekstra, HJ., Roodenburg, JLN., Vaalburg, W., ... Schraffordt Koops, H. (1998). Detection of unknown occult primary tumors using positron emission tomography. Cancer, 82(6), 1160-1166.
  14. Heesters, MAAM., Go, KG., Kamman, RL., Mooyaart, EL., Meertens, H., Paans, AMJ., & Pruim, J. (1998). C-11-tyrosine position emission tomography and H-1 magnetic resonance spectroscopy of the response of brain gliomas to radiotherapy. Neuroradiology, 40(2), 103-108.
  15. Paans, AMJ., Pruim, J., Van Waarde, A., Willemsen, ATM., & Vaalburg, W. (1998). Positron emission tomography in oncology - In vivo measurement of protein synthesis in tumors. In B. Gulyas, & HW. MullerGartner (Eds.), POSITRON EMISSION TOMOGRAPHY: CRITICAL ASSESSMENT OF RECENT TRENDS (pp. 185-198). (NATO ADVANCED SCIENCE INSTITUTE SERIES, SUB-SERIES 3, HIGH TECHNOLOGY; Vol. 51). DORDRECHT: Springer.
  16. 1997
  17. Jansen, HML., Paans, AMJ., Vliet, AMV., VeenmavanderDuin, L., BolwijnMeijer, CJW., Pruim, J., ... Korf, J. (1997). Cobalt-55 positron emission tomography in ischemic stroke. Clinical neurology and neurosurgery, 99(1), 6-10.
  18. Kole, AC., Pruim, J., Nieweg, OE., vanGinkel, RJ., Hoekstra, HJ., Vaalburg, W., & Schraffordt Koops, H. (1997). PET with 1-[1-carbon-11]-tyrosine to visualize tumors and measure protein synthesis rates. Journal of Nuclear Medicine, 38(2), 191-195.
  19. 1996

ID: 130635